ML

Murarisetty Lakshmi Kumari

Active Director Director DIN 03523195
DIN 03523195 First appointment Dec 2004 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Murarisetty Lakshmi Kumari

Data last updated:

Murarisetty Lakshmi Kumari is a Director at B L Pharma Limited (since 2004). The company operates in Pharma.

DIN 03523195
Primary Designation Director
Industry Pharma
First Appointment 02 Dec 2004
Oldest Company Age 28 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
B L Pharma Limited U24230TG1998PLC029483
Director02 Dec 20041998Active

Board colleagues of Murarisetty Lakshmi Kumari

NameDINCompanyDesignation
Murarisetty Sunilmohan02835740B L Pharma LimitedDirector
Murarisetty Venkata Srinivasa Rao03523189B L Pharma LimitedManaging Director

Directorship timeline

Open interactive timeline →
B L Pharma Limited
Premium access

Shareholding and investment profile for Murarisetty Lakshmi Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Murarisetty Lakshmi Kumari

Murarisetty Lakshmi Kumari currently holds 1 directorship: B L Pharma Limited (Director, since 02 Dec 2004).

Murarisetty Lakshmi Kumari was first appointed on 02 Dec 2004 as Director at B L Pharma Limited.

The current boards of Murarisetty Lakshmi Kumari's companies include Murarisetty Sunilmohan (B L Pharma Limited), Murarisetty Venkata Srinivasa Rao (B L Pharma Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available